Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom.
Wellcome Centre for Integrative Neuroimaging, FMRIB Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Magn Reson Med. 2020 Feb;83(2):731-748. doi: 10.1002/mrm.27956. Epub 2019 Sep 12.
To compare cerebral blood flow (CBF) and cerebrovascular reserve (CVR) quantification from Turbo-QUASAR (quantitative signal targeting with alternating radiofrequency labeling of arterial regions) arterial spin labeling (ASL) and single post-labeling delay pseudo-continuous ASL (PCASL).
A model-based method was developed to quantify CBF and arterial transit time (ATT) from Turbo-QUASAR, including a correction for magnetization transfer effects caused by the repeated labeling pulses. Simulations were performed to assess the accuracy of the model-based method. Data from an in vivo experiment conducted on a healthy cohort were retrospectively analyzed to compare the CBF and CVR (induced by acetazolamide) measurement from Turbo-QUASAR and PCASL on the basis of global and regional differences. The quality of the two ASL data sets was examined using the coefficient of variation (CoV).
The model-based method for Turbo-QUASAR was accurate for CBF estimation (relative error was 8% for signal-to-noise ratio = 5) in simulations if the bolus duration was known. In the in vivo experiment, the mean global CVR estimated by Turbo-QUASAR and PCASL was between 63% and 64% and not significantly different. Although global CBF values of the two ASL techniques were not significantly different, regional CBF differences were found in deep gray matter in both pre- and postacetazolamide conditions. The CoV of Turbo-QUASAR data was significantly higher than PCASL.
Both ASL techniques were effective for quantifying CBF and CVR, despite the regional differences observed. Although CBF estimated from Turbo-QUASAR demonstrated a higher variability than PCASL, Turbo-QUASAR offers the advantage of being able to measure and control for variation in ATT.
比较 Turbo-QUASAR(动脉区域交替射频标记的定量信号靶向)动脉自旋标记(ASL)和单后标记延迟伪连续 ASL(PCASL)的脑血流(CBF)和脑血管储备(CVR)定量。
开发了一种基于模型的方法,从 Turbo-QUASAR 中定量 CBF 和动脉传输时间(ATT),包括对重复标记脉冲引起的磁化转移效应的校正。进行了模拟以评估基于模型的方法的准确性。对健康队列进行的体内实验的数据进行了回顾性分析,根据全局和区域差异,比较了 Turbo-QUASAR 和 PCASL 测量的 CBF 和 CVR(由乙酰唑胺诱导)。使用变异系数(CoV)检查两个 ASL 数据集的质量。
如果知道脉冲持续时间,则 Turbo-QUASAR 的基于模型的方法可准确估计 CBF(信噪比为 5 时相对误差为 8%)。在体内实验中,Turbo-QUASAR 和 PCASL 估计的平均全局 CVR 在 63%到 64%之间,没有显着差异。尽管两种 ASL 技术的全局 CBF 值没有显着差异,但在乙酰唑胺前后条件下,深部灰质均发现了局部 CBF 差异。Turbo-QUASAR 数据的 CoV 显着高于 PCASL。
尽管观察到了局部差异,但两种 ASL 技术都可以有效地定量 CBF 和 CVR。尽管从 Turbo-QUASAR 估计的 CBF 显示出比 PCASL 更高的可变性,但 Turbo-QUASAR 具有能够测量和控制 ATT 变化的优势。